It might sound strange at first that a diabetes and weight loss drug has the potential to treat addiction disorders, but observations from researchers have led to emerging data, anecdotal reports, and pharmacoepidemiologic findings that suggest GLP-1 drugs could be effective for addiction by reducing drug use and craving through the modulation of reward pathways, stress responses, and cognitive functions
Source: Pocket Manual of Therapy (Bartoccioni et al.) / FDA News To view or add a comment, sign in 186 followers
DSIP Compounded in a licensed US 503A pharmacy Sleep Research Peptide
Ugyanakkor fontos kockzat, hogy az elhzott betegek mintegy 30%-nl jelen lv evszavarokat a kezels akr slyosbthatja is
If you take both metformin and tirzepatide, your risk of B12 deficiency is compounded (no pun intended)
While all treatments raised DNA fragmentation in controldiet animals, they effectively reduced fragmentation in AGEdiet animals, returning it to control levels (Fig